Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:26 pm Unchanged | 2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | LAV Biosciences Fund V L.P. | 25,406,680 5.300% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:23 pm Purchase | 2023-12-31 | 13G | Burning Rock Biotech Limited BNR | LAV Biosciences Fund V L.P. | 438,421 5.100% | 438,421 (New Position) | Filing History |
| 2024-02-13 5:21 pm Unchanged | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,901,566 4.700% | 0 (Unchanged) | Filing History |
| 2023-02-06 2:45 pm Sale | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,901,566 6.100% | -63,304 (-2.14%) | Filing History |
| 2022-12-29 2:57 pm Sale | 2022-12-27 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 2,964,870 6.180% | -1,816,696 (-37.99%) | Filing History |
| 2022-02-09 12:29 pm Purchase | 2021-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | LAV Biosciences Fund V L.P. | 4,781,566 18.900% | 4,781,566 (New Position) | Filing History |
| 2022-02-09 12:17 pm Purchase | 2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | LAV Biosciences Fund V L.P. | 25,406,680 7.800% | 25,406,680 (New Position) | Filing History |